| Recruiting | Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda NCT07276360 | Uganda Cancer Institute | Phase 2 |
| Recruiting | AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors NCT07454642 | Avacta Life Sciences Ltd | Phase 1 |
| Not Yet Recruiting | QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therap NCT07141186 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors NCT07020117 | Aktis Oncology, Inc. | Phase 1 |
| Recruiting | External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Sta NCT06543576 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women NCT07398313 | Saveetha University | N/A |
| Recruiting | IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: NCT06654011 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Not Yet Recruiting | Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcino NCT06805864 | Gunma University | Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patie NCT06783153 | Mansoura University | Phase 1 / Phase 2 |
| Active Not Recruiting | RT for Adenocarcinoma/Adenosquamous Carcinoma NCT07153952 | Peking Union Medical College Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | Primary Cervical Cancer Screening by Self-sampling HPV Test NCT05613283 | Peking University People's Hospital | — |
| Withdrawn | Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervica NCT03834571 | AIDS Malignancy Consortium | Phase 2 |
| Unknown | Clinical Evaluation of Detection of High Risk HPV in Urine NCT05210348 | Peking University People's Hospital | — |
| Active Not Recruiting | Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Be NCT04622670 | M.D. Anderson Cancer Center | N/A |
| Completed | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive S NCT03738228 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma NCT03742869 | Lei Li | — |
| Completed | Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer NCT02921269 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) Duri NCT02466971 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer NCT02562729 | Shanghai Gynecologic Oncology Group | Phase 2 |
| Active Not Recruiting | Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer NCT02257528 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer NCT02164461 | Advaxis, Inc. | Phase 1 |
| Terminated | Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervi NCT02140021 | M.D. Anderson Cancer Center | N/A |
| Completed | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance NCT02020707 | Mayo Clinic | Phase 1 |
| Terminated | MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer NCT01992861 | University of Washington | — |
| Active Not Recruiting | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical NCT01649089 | GOG Foundation | N/A |
| Completed | Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer NCT01693783 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer NCT01711515 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced C NCT01414608 | GOG Foundation | Phase 3 |
| Completed | Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer NCT02880007 | Institut de Cancérologie de Lorraine | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer NCT01266460 | Gynecologic Oncology Group | Phase 2 |
| Unknown | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA NCT01295502 | Gynecologic Oncology Group | Phase 1 |
| Completed | Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer NCT01267253 | Gynecologic Oncology Group | Phase 2 |
| Completed | Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Can NCT01281852 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Re NCT01266447 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer NCT01048853 | M.D. Anderson Cancer Center | N/A |
| Completed | Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Und NCT01101451 | GOG Foundation | Phase 3 |
| Completed | Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Can NCT01026792 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurre NCT00803062 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Ixabepilone to Treat Cervical Cancer NCT00924066 | National Cancer Institute (NCI) | Phase 2 |
| Completed | FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer NCT00559377 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Th NCT00416455 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer NCT00054444 | Gynecologic Oncology Group | Phase 1 |
| Completed | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing S NCT00460356 | Gynecologic Oncology Group | — |
| Completed | Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be NCT00389974 | National Cancer Institute (NCI) | Phase 2 |
| Completed | ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer NCT00309959 | Gynecologic Oncology Group | Phase 2 |
| Completed | Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced NCT00369122 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer NCT00262821 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer NCT00217633 | Gynecologic Oncology Group | Phase 2 |
| Completed | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage NCT00104910 | Gynecologic Oncology Group | Phase 1 |
| Terminated | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer NCT00070317 | Gynecologic Oncology Group | N/A |
| Completed | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer NCT00068549 | Gynecologic Oncology Group | Phase 1 |
| Completed | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recu NCT00064077 | Gynecologic Oncology Group | Phase 3 |
| Completed | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer NCT00057863 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer NCT00039442 | Gynecologic Oncology Group | Phase 2 |
| Completed | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Ane NCT00017004 | Gynecologic Oncology Group | Phase 3 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |